Asset Details
Do you wish to reserve the book?
The impact of Mycoplasma pneumoniae infection on platelets in children with immune thrombocytopenia: a real-world study from China
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The impact of Mycoplasma pneumoniae infection on platelets in children with immune thrombocytopenia: a real-world study from China
Do you wish to request the book?
The impact of Mycoplasma pneumoniae infection on platelets in children with immune thrombocytopenia: a real-world study from China
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The impact of Mycoplasma pneumoniae infection on platelets in children with immune thrombocytopenia: a real-world study from China
2025
Overview
Mycoplasma pneumoniae (M. pneumoniae), as one of the susceptible pathogens during childhood, may lead to severe mycoplasmal pneumonia and affect platelet fluctuations. We prospectively collected data on persistent/chronic ITP children who were infected with M. pneumoniae infection from August 2023 to December 2023. There were 64 patients (40 males) with a median age of 7.08 years (range 4.30 to 9.76) enrolled in this study. Overall, 33 (51.6%) children received TPO-RAs therapy and 31 (48.4%) received other treatments. The impact of M. pneumoniae infection on platelet count is bidirectional, but thrombocytopenia remains predominant. During M. pneumoniae infection, platelet changes in the TPO-RA group were higher than in the non-TPO-RA group. Thrombocytosis was observed in 6 patients (5 in the TPO-RA group vs. 1 in the non-TPO-RA group). Rescue treatment was implemented in 18 patients (7 in the TPO-RA group vs. 11 in the non-TPO-RA group). Monitoring platelets should be strengthened during M. pneumoniae infection.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
Subject
/ Child
/ Female
/ Humans
/ Male
/ Medicine
/ Oncology
/ Pneumonia, Mycoplasma - blood
/ Pneumonia, Mycoplasma - complications
/ Pneumonia, Mycoplasma - drug therapy
/ Pneumonia, Mycoplasma - epidemiology
/ Purpura, Thrombocytopenic, Idiopathic - blood
/ Purpura, Thrombocytopenic, Idiopathic - complications
/ Purpura, Thrombocytopenic, Idiopathic - drug therapy
We currently cannot retrieve any items related to this title. Kindly check back at a later time.